Mary Babb Randolph Cancer Center

Morgantown, West Virginia 26506-9162

0 studies enrolling now · 8 studies all time

What they study most

Cancer, Hodgkin's Disease, Hodgkin's Lymphoma, Hyperuricemia, Malignant Pleural Mesothelioma, Melanoma, Ovarian Neoplasms, Small Cell Lung Carcinoma, Tumor Lysis Syndrome, Tumors

Studies at this site

• An Efficacy Study of MORAb-009 (Amatuximab) in Subjects With Pleural Mesothelioma — Completed
• Trial in Extensive-Disease Small Cell Lung Cancer (ED-SCLC) Subjects Comparing Ipilimumab Plus Etoposide and Platinum Therapy to Etoposide and Platinum Therapy Alone — Completed
• A Study of Vemurafenib Adjuvant Therapy in Participants With Surgically Resected Cutaneous BRAF-Mutant Melanoma — Completed
• A Phase III Randomized, Double Blind, Placebo Controlled Multi-center Study of Panobinostat for Maintenance of Response in Patients With Hodgkin's Lymphoma (HL) — Completed
• A Phase II Study of MDX-060 in Subjects With Relapsed or Refractory Hodgkin's Disease — Completed
• Rasburicase Versus Allopurinol in Tumor Patients at Risk for Hyperuricemia and Tumor Lysis Syndrome — Completed
• Study of Rasburicase as Treatment or Prevention of Hyperuricemia Associated With Tumor Lysis Syndrome in Patients With Relapsed or Refractory Lymphoma, Leukemia, or Solid Tumor Malignancy — Completed
• A Comparative Pharmacokinetics and Safety Study of OvaRex MAb-B43.13 in Patients With Ovarian Epithelial Carcinoma — Stopped early